Xencor (XNCR) Debt Ratio (2023 - 2026)

Xencor's (XNCR) quarterly Debt Ratio came in at 0.15 in Q1 2026, down 13.68% year-on-year from 0.17 in Q1 2025, and up 7.69% on a QoQ basis from 0.14 in Q4 2025.

Xencor (XNCR) Debt Ratio (2023 - 2026) Analysis & Trends

Xencor (XNCR) has 4 years of Debt Ratio data on file, last reported at 0.15 in Q1 2026.

  • On a quarterly basis, Debt Ratio fell 13.68% year-over-year to 0.15 in Q1 2026; TTM through Mar 2026 was 0.15, a 13.68% decrease from a year earlier, with the FY2025 full-year figure at 0.14, down 20.42% from the prior year.
  • Debt Ratio for Q1 2026 stood at 0.15, up from 0.14 in the prior quarter.
  • Over the last five years, Debt Ratio for XNCR reached as high as 0.21 in Q2 2024 and fell as low as 0.14 in Q4 2025.
  • Historically, Debt Ratio has averaged 0.17 across 4 years, with a median of 0.17 in 2024.
  • On a YoY basis, Debt Ratio climbed as much as 11.32% in 2025 and fell as far as 22.88% in 2025.
  • Year by year, Debt Ratio stood at 0.2 in 2023, then decreased by 12.46% to 0.17 in 2024, then declined by 20.42% to 0.14 in 2025, then climbed by 7.69% to 0.15 in 2026.
  • Per Business Quant data, the three most recent Debt Ratio figures were 0.15 in Q1 2026, 0.14 in Q4 2025, and 0.15 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 1.41
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.11
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.05
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Xencor 1.47 Bn 1.09 Bn - 0.15

Historic Data

Download Data
DateValue
Mar 31, 2026 0.15
Dec 31, 2025 0.14
Sep 30, 2025 0.15
Jun 30, 2025 0.16
Mar 31, 2025 0.17
Dec 31, 2024 0.17
Sep 30, 2024 0.17
Jun 30, 2024 0.21
Mar 31, 2024 0.21
Dec 31, 2023 0.20